|Bid||0.310 x 0|
|Ask||0.315 x 0|
|Day's Range||0.3050 - 0.3200|
|52 Week Range||0.1900 - 0.4600|
|Beta (3Y Monthly)||1.50|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.38|
TORONTO, ON / ACCESSWIRE / December 10, 2018 / Theralase Technologies Inc.(" Theralase® " or the " Company ") ( TSXV: TLT ) ( OTCQB: TLTFF ), a clinical stage pharmaceutical company ...
Theralase Granted Canadian Patent for Metal-Glycoprotein Complexes Used to Hunt Cancer Cells and When Laser Light Activated Destroy Them TORONTO, ON / ACCESSWIRE / November 15, 2018 / Theralase Technologies ...
Theralase Provides Update on 9 Months Post Treatment Cystoscopy Analysis TORONTO, ONTARIO / ACCESSWIRE / November 8, 2018 / Theralase Technologies Inc. (" Theralase® " or the " Company ")( ...
Vancouver, British Columbia--(Newsfile Corp. - July 26, 2018) - On BNN Sat July 28 & Sun July 29, 2018 - BTV-Business Television goes on location with four small cap companies in popular sectors. Full EpisodeBlissCo Cannabis Corp. (CSE: BLIS) — BTV shares how this CEO's distribution background will help his company profit in the rapidly expanding cannabis market. See Feature Critical Elements Corp. (TSXV: CRE) (OTCQX: CRECF) — Electric vehicle demand spells opportunity for the key ...
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Medical Devices industry: Titan Medical, Patient Home Monitoring, Zecotek Photonics, and Theralase Technologies. The TSX Venture Exchange gained 5.05 points, or 0.63%, to finish at 802.60. Today's stocks of interest consist of: Titan Medical Inc. (TSX: TMD), Patient Home Monitoring Corporation (TSX-V: PHM), Zecotek Photonics Inc. (TSX-V: ZMS), and Theralase Technologies Inc. (TSX-V: TLT).